Hind Hafsi

681 total citations
12 papers, 524 citations indexed

About

Hind Hafsi is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Hind Hafsi has authored 12 papers receiving a total of 524 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 4 papers in Biotechnology. Recurrent topics in Hind Hafsi's work include Cancer-related Molecular Pathways (10 papers), Cancer Research and Treatments (4 papers) and Cell death mechanisms and regulation (3 papers). Hind Hafsi is often cited by papers focused on Cancer-related Molecular Pathways (10 papers), Cancer Research and Treatments (4 papers) and Cell death mechanisms and regulation (3 papers). Hind Hafsi collaborates with scholars based in France, United Kingdom and Tunisia. Hind Hafsi's co-authors include Pierre Hainaut, Magali Olivier, Charlotte Sagne, Virginie Marcel, Dandan Ma, Jean‐Christophe Bourdon, Bertrand Mollereau, Kevin J. Harrington, Holly E. Barker and Martin McLaughlin and has published in prestigious journals such as Oncogene, Cell Death and Differentiation and Antioxidants and Redox Signaling.

In The Last Decade

Hind Hafsi

12 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hind Hafsi France 10 385 301 93 67 50 12 524
Ramona Schulz‐Heddergott Germany 8 339 0.9× 288 1.0× 143 1.5× 48 0.7× 64 1.3× 15 531
Gilda P. Chau United States 12 399 1.0× 392 1.3× 123 1.3× 87 1.3× 22 0.4× 16 553
Paule Seité France 15 424 1.1× 331 1.1× 76 0.8× 45 0.7× 65 1.3× 28 637
Ariane Scoumanne United States 13 614 1.6× 227 0.8× 103 1.1× 40 0.6× 63 1.3× 16 753
Andrea Bisso Italy 10 518 1.3× 291 1.0× 159 1.7× 54 0.8× 54 1.1× 17 692
Edward Tom United States 5 469 1.2× 365 1.2× 97 1.0× 77 1.1× 30 0.6× 5 657
Woo-Jeong Jeong South Korea 12 497 1.3× 260 0.9× 94 1.0× 23 0.3× 46 0.9× 14 665
Chaitanyananda B. Koppikar India 3 390 1.0× 421 1.4× 174 1.9× 42 0.6× 69 1.4× 3 645
Verónica Calvo United States 9 265 0.7× 218 0.7× 167 1.8× 33 0.5× 41 0.8× 13 513
Jack Wu United States 14 625 1.6× 251 0.8× 196 2.1× 29 0.4× 28 0.6× 18 778

Countries citing papers authored by Hind Hafsi

Since Specialization
Citations

This map shows the geographic impact of Hind Hafsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hind Hafsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hind Hafsi more than expected).

Fields of papers citing papers by Hind Hafsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hind Hafsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hind Hafsi. The network helps show where Hind Hafsi may publish in the future.

Co-authorship network of co-authors of Hind Hafsi

This figure shows the co-authorship network connecting the top 25 collaborators of Hind Hafsi. A scholar is included among the top collaborators of Hind Hafsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hind Hafsi. Hind Hafsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Hafsi, Hind, et al.. (2019). p53, stem cell biology and childhood blastomas. Current Opinion in Oncology. 31(2). 84–91. 14 indexed citations
2.
Hafsi, Hind, Magnus T. Dillon, Holly E. Barker, et al.. (2018). Combined ATR and DNA-PK Inhibition Radiosensitizes Tumor Cells Independently of Their p53 Status. Frontiers in Oncology. 8. 245–245. 41 indexed citations
3.
Patel, Radhika, Holly E. Barker, Joan Kyula, et al.. (2017). An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation. Radiotherapy and Oncology. 122(3). 470–475. 20 indexed citations
4.
Dillon, Magnus T., Holly E. Barker, Malin Pedersen, et al.. (2016). Radiosensitization by the ATR Inhibitor AZD6738 through Generation of Acentric Micronuclei. Molecular Cancer Therapeutics. 16(1). 25–34. 82 indexed citations
5.
Hafsi, Hind, Oussama Grissa, Hadhami Ben Turkia, et al.. (2016). Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation. Diagnostic Pathology. 11(1). 51–51. 3 indexed citations
6.
Schick, Ulrike, Joan Kyula, Holly E. Barker, et al.. (2015). Trametinib radiosensitises RAS- and BRAF-mutated melanoma by perturbing cell cycle and inducing senescence. Radiotherapy and Oncology. 117(2). 364–375. 26 indexed citations
7.
Hafsi, Hind, Daniela Santos‐Silva, Stéphanie Courtois-Cox, & Pierre Hainaut. (2013). Effects of Δ40p53, an isoform of p53 lacking the N-terminus, on transactivation capacity of the tumor suppressor protein p53. BMC Cancer. 13(1). 134–134. 41 indexed citations
8.
Ma, Dandan, Pierre Dourlen, Gilles Chatelain, et al.. (2012). Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation. Cell Death and Differentiation. 20(1). 108–116. 42 indexed citations
9.
Hafsi, Hind & Pierre Hainaut. (2011). Redox Control and Interplay Between p53 Isoforms: Roles in the Regulation of Basal p53 Levels, Cell Fate, and Senescence. Antioxidants and Redox Signaling. 15(6). 1655–1667. 41 indexed citations
10.
Marcel, Virginie, Charlotte Sagne, Hind Hafsi, et al.. (2011). Biological functions of p53 isoforms through evolution: lessons from animal and cellular models. Cell Death and Differentiation. 18(12). 1815–1824. 158 indexed citations
11.
Hafsi, Hind & Pierre Hainaut. (2011). Pharmacological rescue of p53 in cancer cells: The soloist meets the PRIMA donna. Cell Cycle. 10(6). 879–878. 2 indexed citations
12.
Marcel, Virginie, Vineetha Vijayakumar, Lynnette Fernandez‐Cuesta, et al.. (2010). p53 regulates the transcription of its Δ133p53 isoform through specific response elements contained within the TP53 P2 internal promoter. Oncogene. 29(18). 2691–2700. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ramona Schulz‐Heddergott Breakdown of academic impact, for papers by Gilda P. Chau Breakdown of academic impact, for papers by Paule Seité Breakdown of academic impact, for papers by Ariane Scoumanne Breakdown of academic impact, for papers by Andrea Bisso Breakdown of academic impact, for papers by Edward Tom Breakdown of academic impact, for papers by Woo-Jeong Jeong Breakdown of academic impact, for papers by Chaitanyananda B. Koppikar Breakdown of academic impact, for papers by Verónica Calvo Breakdown of academic impact, for papers by Jack Wu
Rankless by CCL
2026